Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway.

Wang B, Shi L, Sun X, Wang L, Wang X, Chen C.

J Cell Mol Med. 2016 May;20(5):920-9. doi: 10.1111/jcmm.12781. Epub 2016 Mar 10.

2.

Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells.

Stec M, Szatanek R, Baj-Krzyworzeka M, Baran J, Zembala M, Barbasz J, Walig├│rska A, Dobrucki JW, Mytar B, Szczepanik A, Siedlar M, Drabik G, Urbanowicz B, Zembala M.

J Transl Med. 2015 Dec 1;13:376. doi: 10.1186/s12967-015-0737-0.

3.

The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.

Boyle ST, Faulkner JW, McColl SR, Kochetkova M.

Mol Cancer. 2015 Jun 6;14:115. doi: 10.1186/s12943-015-0394-1.

5.

CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.

Nandi B, Pai C, Huang Q, Prabhala RH, Munshi NC, Gold JS.

PLoS One. 2014 May 27;9(5):e97566. doi: 10.1371/journal.pone.0097566. eCollection 2014.

6.

Bronchial airway gene expression in smokers with lung or head and neck cancer.

Van Dyck E, Nazarov PV, Muller A, Nicot N, Bosseler M, Pierson S, Van Moer K, Palissot V, Mascaux C, Knolle U, Ninane V, Nati R, Bremnes RM, Vallar L, Berchem G, Schlesser M.

Cancer Med. 2014 Apr;3(2):322-36. doi: 10.1002/cam4.190. Epub 2014 Feb 4.

7.

Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.

Geraghty P, Hardigan A, Foronjy RF.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):559-70. doi: 10.1165/rcmb.2013-0258OC.

8.

Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.

Son DS, Kabir SM, Dong Y, Lee E, Adunyah SE.

J Inflamm (Lond). 2013 Jun 25;10(1):25. doi: 10.1186/1476-9255-10-25.

9.

CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.

Wald O, Shapira OM, Izhar U.

Theranostics. 2013;3(1):26-33. doi: 10.7150/thno.4922. Epub 2013 Jan 13. Review.

10.

Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.

Hayata K, Iwahashi M, Ojima T, Katsuda M, Iida T, Nakamori M, Ueda K, Nakamura M, Miyazawa M, Tsuji T, Yamaue H.

PLoS One. 2013;8(1):e53131. doi: 10.1371/journal.pone.0053131. Epub 2013 Jan 25.

11.

Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.

Wu J, Du J, Liu L, Li Q, Rong W, Wang L, Wang Y, Zang M, Wu Z, Zhang Y, Qu C.

PLoS One. 2012;7(12):e50035. doi: 10.1371/journal.pone.0050035. Epub 2012 Dec 5.

12.

The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Weaver CT, Elson CO, Fouser LA, Kolls JK.

Annu Rev Pathol. 2013 Jan 24;8:477-512. doi: 10.1146/annurev-pathol-011110-130318. Epub 2012 Nov 15. Review.

13.

Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.

Kezic JM, Glant TT, Rosenbaum JT, Rosenzweig HL.

Arthritis Res Ther. 2012 Jan 23;14(1):R18. doi: 10.1186/ar3697.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk